Hepatitis B and C rates are significantly increased in certain solid tumors: A large retrospective study

Kocoglu H., Karaca M., Tural D., Hocaoglu E., OKUTURLAR Y., Fetullahoglu Z., ...Daha Fazla

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.14, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 14
  • Basım Tarihi: 2018
  • Doi Numarası: 10.4103/0973-1482.174544
  • Dergi Adı: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Cancer, hepatitis B, hepatitis C, prevalence, RECEIVING CYTOTOXIC CHEMOTHERAPY, VIRUS-INFECTION, CANCER-PATIENTS, IMMUNOSUPPRESSIVE THERAPY, AMERICAN SOCIETY, REACTIVATION, RECOMMENDATIONS, SEROPREVALENCE, MALIGNANCIES, REPLICATION
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Objective: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are associated with significant morbidity and mortality among cancer patients who received cytotoxic chemotherapy. The aim of current study was to elucidate the prevalence of HBV and HCV among large population of solid cancers and lymphoma and to compare them with large number of control group.